Pelthos Therapeutics Inc. — Form D
Pelthos Therapeutics Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-19. The offering totals $18.0M, of which $18.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-11-19
- Form: D
- Accession: 0001919246-25-000006
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $18.0M
- Amount sold: $18.0M
- Investors: 8
- Date of first sale: 2025-11-06
- Revenue range: Decline to Disclose
- SEC file number: 021-564384
Issuer
- Name: Pelthos Therapeutics Inc.
- CIK: 0001919246
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2021
- Address: 4020 STIRRUP CREEK DRIVE, DURHAM, NC, 27703
- Phone: 919-908-2400
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Richard Baxter | Director | Durham, NC |
| Todd Davis | Director | Wayne, PA |
| Ezra Friedberg | Director | Durham, NC |
| Peter Greenleaf | Director | Durham, NC |
| Richard Malamut | Director | Durham, NC |
| Matthew Pauls | Director | Durham, NC |
| Scott Plesha | Director | Durham, NC |
| Francis Knuettel II | Executive Officer | Denver, CO |
| Scott Plesha | Executive Officer | Durham, NC |
| Sai Rangarao | Executive Officer | Durham, NC |
| Francis Knuettel | Executive Officer | Freehold, NJ |
| Chia-Lin Simmons | Director | Freehold, NJ |
| Eric Lang | Executive Officer | Plainsboro, NJ |
Other filings by this issuer (3)
More